| scholarly article | Q13442814 |
| P50 | author | L. Darryl Quarles | Q55873742 |
| Zhousheng Xiao | Q58324391 | ||
| P2093 | author name string | Xiaobin Han | |
| Linqiang Li | |||
| Jiancheng Yang | |||
| Gwendalyn King | |||
| P2860 | cites work | Mutation of the mouse klotho gene leads to a syndrome resembling ageing | Q24328782 |
| Fibroblast growth factor 23 inhibits extrarenal synthesis of 1,25-dihydroxyvitamin D in human monocytes | Q24604832 | ||
| LPS induces CD40 gene expression through the activation of NF-kappaB and STAT-1alpha in macrophages and microglia | Q24685951 | ||
| Klotho and phosphate are modulators of pathologic uremic cardiac remodeling | Q27342649 | ||
| Klotho converts canonical FGF receptor into a specific receptor for FGF23 | Q28272505 | ||
| 1,25-dihydroxyvitamin D(3) regulation of fibroblast growth factor-23 expression in bone cells: evidence for primary and secondary mechanisms modulated by leptin and interleukin-6 | Q28572351 | ||
| Regulation of fibroblast growth factor-23 signaling by klotho | Q28587100 | ||
| 25(OH) vitamin D suppresses macrophage adhesion and migration by downregulation of ER stress and scavenger receptor A1 in type 2 diabetes | Q33632511 | ||
| ADAM-17: the enzyme that does it all. | Q33737421 | ||
| Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis | Q33932297 | ||
| FGF23 induces left ventricular hypertrophy | Q34028891 | ||
| FGF23 is a novel regulator of intracellular calcium and cardiac contractility in addition to cardiac hypertrophy | Q34035797 | ||
| Vitamin D therapy and cardiac structure and function in patients with chronic kidney disease: the PRIMO randomized controlled trial. | Q34254721 | ||
| Klotho interferes with a novel FGF-signalling pathway and insulin/Igf-like signalling to improve longevity and stress resistance in Caenorhabditis elegans | Q34322391 | ||
| A comparative transcriptome analysis identifying FGF23 regulated genes in the kidney of a mouse CKD model. | Q34412241 | ||
| Vitamin D and risk of cause specific death: systematic review and meta-analysis of observational cohort and randomised intervention studies | Q34413128 | ||
| Klotho deficiency causes vascular calcification in chronic kidney disease | Q34457281 | ||
| Initial FGF23-mediated signaling occurs in the distal convoluted tubule | Q34695191 | ||
| Unexpected actions of vitamin D: new perspectives on the regulation of innate and adaptive immunity | Q34739582 | ||
| Klotho gene deficiency causes salt-sensitive hypertension via monocyte chemotactic protein-1/CC chemokine receptor 2-mediated inflammation | Q34787751 | ||
| Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease | Q35099518 | ||
| Dynamic regulation of FGF23 by Fam20C phosphorylation, GalNAc-T3 glycosylation, and furin proteolysis | Q35140676 | ||
| FGF-23 associates with death, cardiovascular events, and initiation of chronic dialysis | Q35272291 | ||
| Conditional deletion of Pkd1 in osteocytes disrupts skeletal mechanosensing in mice | Q35559060 | ||
| Klotho gene delivery ameliorates renal hypertrophy and fibrosis in streptozotocin-induced diabetic rats by suppressing the Rho-associated coiled-coil kinase signaling pathway | Q35628451 | ||
| Evidence for a bone-kidney axis regulating phosphate homeostasis | Q35679294 | ||
| Vitamin D status, 1,25-dihydroxyvitamin D3, and the immune system | Q35976984 | ||
| Fibroblast growth factor 23 and Inflammation in CKD | Q36067879 | ||
| Insulin stimulates the cleavage and release of the extracellular domain of Klotho by ADAM10 and ADAM17 | Q36288869 | ||
| Low Vitamin D and High Fibroblast Growth Factor 23 Serum Levels Associate with Infectious and Cardiac Deaths in the HEMO Study | Q36417886 | ||
| Correlation between vitamin D and cardiovascular disease predictors in overweight and obese Koreans | Q36670833 | ||
| CYP24A1 and CYP27B1 polymorphisms modulate vitamin D metabolism in colon cancer cells. | Q36778121 | ||
| Fibroblast growth factor-23: what we know, what we don't know, and what we need to know | Q37162723 | ||
| Macrophages in renal disease | Q37826304 | ||
| Roles of phosphate and fibroblast growth factor 23 in cardiovascular disease. | Q38200883 | ||
| Inflammatory processes in renal fibrosis. | Q38225047 | ||
| Identification of cleavage sites leading to the shed form of the anti-aging protein klotho | Q38305115 | ||
| Role of innate and adaptive immune mechanisms in cardiac injury and repair | Q38329556 | ||
| Shedding of klotho by ADAMs in the kidney | Q38855334 | ||
| The isolation and characterization of murine macrophages | Q39485692 | ||
| 1,25-Dihydroxyvitamin D₃ Promotes High Glucose-Induced M1 Macrophage Switching to M2 via the VDR-PPARγ Signaling Pathway | Q40189940 | ||
| Expression of Fgf23 in activated dendritic cells and macrophages in response to immunological stimuli in mice | Q41295557 | ||
| The bone and beyond: 'Dem bones' are made for more than walking. | Q41574661 | ||
| Fibroblast growth factor 23 (FGF23) and alpha-klotho stimulate osteoblastic MC3T3.E1 cell proliferation and inhibit mineralization | Q41779344 | ||
| Fibroblast growth factor 23 is a counter-regulatory phosphaturic hormone for vitamin D. | Q42493065 | ||
| FGF23 regulates renal sodium handling and blood pressure | Q42952198 | ||
| Pathogenic role of Fgf23 in Hyp mice. | Q46921328 | ||
| Furin-like proprotein convertases are central regulators of the membrane type matrix metalloproteinase-pro-matrix metalloproteinase-2 proteolytic cascade in atherosclerosis. | Q51456725 | ||
| Regulation of CYP27B1 and CYP24A1 hydroxylases limits cell-autonomous activation of vitamin D in dendritic cells. | Q53061723 | ||
| Regulation of renal fibrosis by macrophage polarization. | Q53622903 | ||
| Ex vivo programmed macrophages ameliorate experimental chronic inflammatory renal disease | Q59391845 | ||
| Fibroblast Growth Factor 23 (FGF23) Predicts Progression of Chronic Kidney Disease: The Mild to Moderate Kidney Disease (MMKD) Study | Q59575076 | ||
| Macrophage activation to kill Leishmania tropica: defective intracellular killing of amastigotes by macrophages elicited with sterile inflammatory agents | Q70315127 | ||
| Interferon-gamma augments acute macrophage-mediated renal injury via a glucocorticoid-sensitive mechanism | Q73180340 | ||
| Oncostatin M is a major mediator of cardiomyocyte dedifferentiation and remodeling | Q82360998 | ||
| Reduced Klotho expression level in kidney aggravates renal interstitial fibrosis | Q83456041 | ||
| The failing heart is a major source of circulating FGF23 via oncostatin M receptor activation | Q85894062 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | macrophage | Q184204 |
| P304 | page(s) | 53-67 | |
| P577 | publication date | 2016-01-09 | |
| P1433 | published in | FEBS Letters | Q1388051 |
| P1476 | title | Counter-regulatory paracrine actions of FGF-23 and 1,25(OH)2 D in macrophages | |
| P478 | volume | 590 |
| Q58760717 | 1,25-Dihydroxyvitamin D suppresses M1 macrophages and promotes M2 differentiation at bone injury sites |
| Q64052563 | 25(OH)D3 and 1.25(OH)2D3 inhibits TNF-α expression in human monocyte derived macrophages |
| Q39203308 | Acute lung injury complicating acute kidney injury: A model of endogenous αKlotho deficiency and distant organ dysfunction |
| Q89985486 | Alpha-Klotho, a critical protein for lung health, is not expressed in normal lung |
| Q47989110 | Biology of Fibroblast Growth Factor 23: From Physiology to Pathology |
| Q90469042 | C-FGF23 peptide alleviates hypoferremia during acute inflammation |
| Q38977291 | Cardiac actions of fibroblast growth factor 23. |
| Q58770788 | Cardiovascular Interactions between Fibroblast Growth Factor-23 and Angiotensin II |
| Q41629823 | Differential Regulatory Role of Soluble Klothos on Cardiac Fibrogenesis in Hypertension. |
| Q92822880 | Extracellular Vesicles from Albumin-Induced Tubular Epithelial Cells Promote the M1 Macrophage Phenotype by Targeting Klotho |
| Q38972469 | Extrarenal effects of FGF23. |
| Q98906651 | FGF/FGFR signaling in health and disease |
| Q54960612 | FGF23 Actions on Target Tissues-With and Without Klotho. |
| Q91697808 | FGF23 expression is stimulated in transgenic α-Klotho longevity mouse model |
| Q38728860 | FGF23 from bench to bedside. |
| Q91410209 | FGF23 induced left ventricular hypertrophy mediated by FGFR4 signaling in the myocardium is attenuated by soluble Klotho in mice |
| Q64063902 | FGF23, Biomarker or Target? |
| Q93208168 | Fibroblast growth factor 23 and α-Klotho co-dependent and independent functions |
| Q42704110 | Fibroblast growth factor 23 directly targets hepatocytes to promote inflammation in chronic kidney disease |
| Q37243107 | Inflammation regulates fibroblast growth factor 23 production |
| Q38942965 | Ironing out the cross talk between FGF23 and inflammation |
| Q37695914 | Is Fibroblast growth factor 23 the leading cause of increased mortality among chronic kidney disease patients? A narrative review |
| Q88580595 | Klotho preservation by Rhein promotes toll-like receptor 4 proteolysis and attenuates lipopolysaccharide-induced acute kidney injury |
| Q30249410 | MICS, an easily ignored contributor to arterial calcification in CKD patients |
| Q37312020 | Multiple faces of fibroblast growth factor-23 |
| Q39003429 | Novel Faces of Fibroblast Growth Factor 23 (FGF23): Iron Deficiency, Inflammation, Insulin Resistance, Left Ventricular Hypertrophy, Proteinuria and Acute Kidney Injury |
| Q55221465 | Paracrine Effects of FGF23 on the Heart. |
| Q49833498 | Regulation of vitamin D metabolism following disruption of the microbiota using broad spectrum antibiotics |
| Q90259951 | Renal and extrarenal effects of fibroblast growth factor 23 |
| Q55315635 | Role of Fibroblast Growth Factor-23 in Innate Immune Responses. |
| Q64097117 | Targeted lipid nanoparticle delivery of calcitriol to human monocyte-derived macrophages in vitro and in vivo: investigation of the anti-inflammatory effects of calcitriol |
| Q64118923 | The EPO-FGF23 Signaling Pathway in Erythroid Progenitor Cells: Opening a New Area of Research |
| Q92959917 | The Role of Fibroblast Growth Factor 23 in Inflammation and Anemia |
| Q36963471 | The role of fibroblast growth factor 23 and Klotho in uremic cardiomyopathy |
Search more.